Kabra Drugs Limited Press Release Feb 07 2025

KABRA DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 ,inter alia, to consider and approve This is to inform you that the meeting of the Board of Directors of the Company to be held on Friday, 14th February, 2025 at Registered Office at 05.00 p.m. to transact the business as given below:1.To consider and approve Unaudited financial results for the quarter ending on 31st December, 2024 along with Limited Review Report pursuant to regulation 33 of SEBI (Listed Obligations and Disclosure Requirements) Regulations, 2015;2.To consider any other matter with the permission of the Chairman of the meeting.